NASDAQ:XGN

Exagen Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy XGN

*Your capital is at risk

$4.54

-0.280 (-5.81%)

At Close: Jun 03, 2026

Exagen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -63.16. In total, the insiders bought 2.36M and sold 1.32M XGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-63.16
● Buy	2.36M shares
● Sell	1.32M shares
80% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence Mar 12, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -63.16. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (80% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 16, 2026 Buy	Restricted Stock Units	Mckhann Chas Director	Director	0 Value: $0
Mar 12, 2026 Buy	Stock Option(right to buy) A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	50 000 Value: $158.0K
Mar 12, 2026 Buy	Common Stock A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	75 000 Value: $237.0K
Mar 12, 2026 Buy	Common Stock A-Award	Aballi John President And CEO	CEO / President	150 000 Value: $474.0K
Mar 12, 2026 Buy	Stock Option(right to buy) A-Award	Aballi John President And CEO	CEO / President	100 000 Value: $316.0K
Mar 03, 2026 Sell	Common Stock S-Sale	Aballi John President And CEO	CEO / President	15 698 Value: $56.8K
Mar 03, 2026 Buy	Common Stock A-Award	Aballi John President And CEO	CEO / President	2 535 Value: $8K
Feb 27, 2026 Buy	Common Stock A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	1 511 Value: $5K
Feb 24, 2026 Sell	Common Stock S-Sale	Aballi John President And CEO	CEO / President	11 430 Value: $41.3K
Feb 24, 2026 Sell	Common Stock S-Sale	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	1 584 Value: $6K
Oct 16, 2025 Sell	Common Stock S-Sale	Aballi John President And CEO	CEO / President	31 787 Value: $375.6K
Sep 02, 2025 Sell	Common Stock S-Sale	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	20 466 Value: $200.4K
Sep 02, 2025 Sell	Common Stock S-Sale	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	20 466 Value: $200.4K
Jul 17, 2025 Buy	Restricted Stock Units	Mckhann Chas Director	Director	0 Value: $0
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Kim Paul Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Stokes Frank Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Kim Paul Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Kahn Scott D Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Hooker Ana Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Nova Tina Susan Director	Director	13 500 Value: $99.4K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Nova Tina Susan Director	Director	13 500 Value: $99.4K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Hooker Ana Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Kahn Scott D Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Kim Paul Director	Director	9 000 Value: $66.2K
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Stokes Frank Director	Director	9 000 Value: $66.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EXAGEN INC.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables diff...

Read Full Profile Here